Showing 39,321 - 39,340 results of 131,317 for search '(( a e decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.78s Refine Results
  1. 39321

    Image_4_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  2. 39322
  3. 39323

    Characteristics of the included literature. by Wenpin Cai (13779001)

    Published 2024
    “…The relative abundance of <i>Ruminococcus</i>, <i>Faecalibacterium</i>, and <i>Coprococcus</i> all decreased, with total SMDs of -0.96 (95% CI -1.29 to -0.63, I<sup>2</sup> = 4.8%), -1.13 (95% CI -2.07 to -0.19, I<sup>2</sup> = 80.5%), and -1.66 (95% CI -3.04 to -0.28, I<sup>2</sup> = 91.5%). …”
  4. 39324

    PRISMA flow diagram. by Wenpin Cai (13779001)

    Published 2024
    “…The relative abundance of <i>Ruminococcus</i>, <i>Faecalibacterium</i>, and <i>Coprococcus</i> all decreased, with total SMDs of -0.96 (95% CI -1.29 to -0.63, I<sup>2</sup> = 4.8%), -1.13 (95% CI -2.07 to -0.19, I<sup>2</sup> = 80.5%), and -1.66 (95% CI -3.04 to -0.28, I<sup>2</sup> = 91.5%). …”
  5. 39325
  6. 39326

    Table_6_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  7. 39327

    Table_3_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  8. 39328

    Table_2_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  9. 39329

    Table_1_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.docx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  10. 39330

    Table_7_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  11. 39331

    Table_4_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  12. 39332
  13. 39333
  14. 39334
  15. 39335
  16. 39336

    Data_Sheet_1_Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis.docx by Daniela Ferreira Barreira (10527662)

    Published 2021
    “…<p>Background: The coronavirus disease (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), prompted a global health crisis, with no available specific treatments. …”
  17. 39337
  18. 39338
  19. 39339

    Image_1_High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.pdf by Alessio Amatu (6947912)

    Published 2019
    “…Circulating methylated DNA (cmDNA) assessed by a five-gene panel was previously associated with outcome in chemotherapy treated mCRC patients. …”
  20. 39340

    Table_1_High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.pdf by Alessio Amatu (6947912)

    Published 2019
    “…Circulating methylated DNA (cmDNA) assessed by a five-gene panel was previously associated with outcome in chemotherapy treated mCRC patients. …”